Regents of the University of California’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-39,485
Closed -$3.64M 98
2013
Q2
$3.64M Buy
+39,485
New +$3.64M 1.96% 16